Dissertation > Excellent graduate degree dissertation topics show

The Effects of Four Kinds of Weight Relief Modality for Type 2 Diabetes Mellitus in Rats: A Random, Control Study

Author: RenYiXing
Tutor: WangCunChuan
School: Jinan University
Course: Surgery
Keywords: Gastric bypass surgery Sleeve stomach volume reduction surgery Gastric banding weight loss surgery Type 2 diabetes mellitus Rat model
CLC: R587.1
Type: Master's thesis
Year: 2008
Downloads: 135
Quote: 0
Read: Download Dissertation

Abstract


Objective: To by randomized block control experiments, study the gastric bypass weight loss surgery (GastricBy-pass), sleeve-shaped stomach volume reduction surgery (Sleeve Gastrectomy), gastric banding weight loss surgery (Gastric Lap-Band) and diet (Alimentary Control ) These four weight loss methods, weight control and glycemic control in type 2 diabetes in rats by streptozotocin (STZ) modeling, trying to find new effective treatment in type 2 diabetes (T2DM) and preliminary explore the relationship between the blood glucose control and weight loss, and to analyze the mechanism of action. Methods: type 2 diabetes model, male SD rat peritoneal Symphony radio STZ random approach successfully modeled rats were divided into groups of gastric bypass (GBP group), sleeve-shaped stomach volume reduction surgery group (SG group ), gastric banding weight loss surgery group (GLB group) and diet control group (AC group), respectively, applied to the gastric bypass, sleeve-shaped stomach volume reduction surgery, the helmet the belted weight loss surgery and diet control. 1,4,12,24 weeks after treatment before processing, dynamic observation of the rats body weight, fasting blood glucose (fasting blood glucose), glycosylated hemoglobin (glycosylatedhemoglobin), glucagon-like peptide -1 (GLP-1) glucose-dependent insulin-releasing peptide (GIP) changes. Results: GBP rats after 24 weeks survive 10 SG rats after 24 weeks survived for 14 the GLB rats 24 weeks after 18 survived the AC rats survived 12 after 24 weeks. GBP rats body weight in the first four weeks after surgery than before surgery significantly reduced (t = -8.195, P <0.05): GBP rats fasting blood glucose in the first week after surgery decreased compared with the preoperative statistically significant (t = -4.828, P <0.05), while changes in glycosylated hemoglobin statistically significant (t = -6.066, P <0.05) compared with the preoperative; decline in SG group, GLB group, AC blood glucose in the postoperative four weeks, compared with the preoperative statistically significant (P <0.05) was statistically significant (P <0.05), glycosylated hemoglobin after 12 weeks compared with the preoperative. Rats in each group at each time point GLP-1, GIP change compared with the preoperative not significant (P> 0.05). Conclusion: Several methods for weight loss can lower blood glucose of STZ-induced type 2 diabetic rats, but the most significant gastric bypass surgery effects. GBP postoperative blood glucose decreased with the reduction of the body weight of rats, reduced food intake no significant decline in blood sugar earlier than weight loss. Type 2 diabetic rat above four weight loss method to control blood sugar, not by changing the blood glucagon-like peptide-1, glucose-dependent insulin-releasing peptide level work. Approaches to weight loss, especially the mechanism of gastric bypass surgery in the treatment of type 2 diabetes needs further research and extensive clinical and ultimately cure type 2 diabetes provide new theoretical basis.

Related Dissertations

  1. Relationship between Level of Serum Uric Acid and Lower Extremity Arterial Disease in Patients with Type 2 Diabetes Mellitus,R587.1
  2. Efficacy and Safety of Biphasic Insulin Aspart 30 Once-daily Treatment in Patients with Type 2 Diabetes,R587.1
  3. The Blood Glucose Control and Influencing Factors in Type 2 Diabetic Patients with Oral Hypoglycemic Agents,R587.1
  4. Association of Genetic Variation of UTS2 Gene with Type2 Diabetes Mellitus and Hypertension,R587.1
  5. Effect of Gastric Bypass on the Blood Glucose Level in Type 2 Diabetes Rat Model,R587.1
  6. Relationship between Postprandial Blood Pressure and Lower Extremity Arterial Disease in Patients with Type 2 Diabetes Mellitus,R587.1
  7. The Comparison of Therapeutic Effect and Security between CSⅡ and MDI in Type 2 Diabetes Mellitus,R587.1
  8. The Characteristics of Coronary Angiography in Type 2 Diabetes Mellitus Patients with Suspected Coronary Artery Disease,R587.1
  9. Effect of Whey Protein on Improving Insulin Resistance and the Underlying Mechanisms,R587.1
  10. The Changes of T Lymphocyte Subsets and Costimulatory Molecules Before and After Shuxuetong Treatment in Type 2 Diabetes Subjects with Diabetic Kidney Disease,R692
  11. 50 Cases of Type 2 Diabetic Patients Serum Trace Element and Vitamin Change Analysis,R587.1
  12. Correlation Studies of Plasma Fatty Acids and Type 2 Diabetes Mellitus: Case Control Study,R587.1
  13. Effects of Glycogen Synthase Kiase 3β on the Retinal Ganglion Cells of Glaucoma,R775
  14. Risk Factors and Their Interaction of Type 2 Diabetes Mellitus among Rural Residents in Wang Cheng,R587.1
  15. Effects of New Intravenous Infusions on Blood Glucose Variability in Elderly Type 2 Diabetic Patients,R587.1
  16. Clinical Observation on the Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of 234 Patients with Type 2 Diabetic,R587.1
  17. Comparison of Differences in Bone Mineral Density and Its Related Factors for Patients with Type 2 Diabetes Mellitus of Han, Uygur Nationalities in Xinjiang,R587.1
  18. Energy Supply and Nutritional Intervention Study in Hospitalized Patients with Type 2 Diabetes,R587.1
  19. Expression of Chemerin in Liver of Diet Induced Type 2 Diabetic Rats with IL-6 Intervention,R587.1
  20. Influence of Rosiglitazone on Both Bone Mineral Bensity and the Expression of BMP-2 and Bcl-xL in Osteoblast in OLETF Rats,R587.1
  21. Bcl-xL and Fas Protein Change in Spermatogenic Cells of OLETF Rat Testes and Rosiglitazone Intervention Effect,R587.1

CLC: > Medicine, health > Internal Medicine > Endocrine diseases and metabolic diseases > Islet disease > Diabetes
© 2012 www.DissertationTopic.Net  Mobile